Emerging Small-Molecule Treatments for Multiple Sclerosis: Focus on B Cells

F1000Research - United Kingdom
doi 10.12688/f1000research.16495.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

B Cells in Multiple Sclerosis

Autoimmunity
AllergyImmunology
2017English

Emerging Therapies for Relapsing Multiple Sclerosis

Archives of Neurology
2009English

Emerging Treatments in Type 2 Diabetes: Focus on Canagliflozin

Therapeutics and Clinical Risk Management
2014English

Emerging Immunopharmacological Targets in Multiple Sclerosis

Journal of the Neurological Sciences
Neurology
2015English

Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib

Seminars in Hematology
Hematology
2009English

Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis

Advances in Therapy
MedicinePharmacology
2019English

Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors

Biology
ImmunologyMolecular BiologyGeneticsBiochemistryMicrobiology Biological SciencesAgricultural
2012English

Focus on Emerging Technologies

Applied Mechanics Reviews
Mechanical Engineering
1991English

Benefit–risk Assessment of New and Emerging Treatments for Hepatitis C: Focus on Simeprevir and Sofosbuvir

Drug, Healthcare and Patient Safety
Health PolicyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy